Follow The Filings

SLN Silence Therapeutics

Silence Therapeutics earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEFA14A
DEFA14A
8-K 1.01,7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13D/A —
424B5
8-K 1.01,8.01,9.01
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
424B5
8-K/A 5.02
SCHEDULE 13D/A —
8-K 7.01,9.01
8-K 5.07
8-K 8.01,9.01
424B5
8-K 1.01,1.02,8.01,9.01
8-K 2.02,9.01
10-Q
DEF 14A
8-K 2.02,7.01,9.01
10-K

Insider forms

Forms 3, 4 and 5 from EDGAR, 4 rows shown

Filed Form Detail Links
4 Period Aug 10, 2026
4 Period Jun 29, 2026
4 Period Aug 3, 2025
4 Period Jan 2, 2026 (2 forms)

5 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.